logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Manouchehr Shahbaz

This inventor holds 8 USPTO granted patents and 7 published patent applications. Top assignee: Auspex Pharmaceuticals, Inc.. Active years: 2012-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manouchehr Shahbaz. Retrieved from https://idiyas.com/inventor/manouchehr-shahbaz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 75.0

Average Co-Inventor Count = 5.3

ph-index = 4

Forward Citations = 47(Granted Patents)


Company Filing History:

goldMedal8 out of 76 
 
Auspex Pharmaceuticals, Inc.
 patents

Years Active: 2012-2023

Loading Chart...
8 patents (USPTO):Explore Patents
1. 11666566 - Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 (2023-06-06),
2. 11033540 - Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 (2021-06-15),
3. 9814708 - Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 (2017-11-14),
4. 9550780 - Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 (2017-01-24),
5. 9346800 - Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 (2016-05-24),
6. 9296739 - Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 (2016-03-29),
7. 9233959 - Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 (2016-01-12),
8. 8227451 - Phenylacetic acid inhibitors of cyclooxygenase (2012-07-24),

Title: Manouchehr Shahbaz: Innovator in Pharmaceutical Compositions

Introduction

Manouchehr Shahbaz is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new compositions aimed at treating chronic hyperkinetic movement disorders. With a total of 8 patents to his name, Shahbaz continues to push the boundaries of innovation in his field.

Latest Patents

One of his latest patents focuses on the formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 (VMAT2). This invention relates to new pharmaceutical compositions comprising benzoquinoline compounds, which are designed to inhibit VMAT2 activity in subjects. This innovative approach aims to provide effective treatment options for individuals suffering from chronic hyperkinetic movement disorders.

Career Highlights

Shahbaz has established himself as a key figure in the pharmaceutical industry through his work at Auspex Pharmaceuticals, Inc. His research and inventions have garnered attention for their potential impact on treatment methodologies. His dedication to advancing pharmaceutical science is evident in his numerous patents and ongoing research efforts.

Collaborations

Throughout his career, Shahbaz has collaborated with notable professionals in the field, including Thomas George Gant and Andreas Sommer. These collaborations have further enriched his research and contributed to the development of innovative solutions in pharmaceuticals.

Conclusion

Manouchehr Shahbaz is a distinguished inventor whose work in pharmaceutical compositions has the potential to transform treatment options for chronic hyperkinetic movement disorders. His contributions to the field, marked by his patents and collaborations, highlight his commitment to innovation and excellence in pharmaceutical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…